Your browser doesn't support javascript.
loading
Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer.
Sutera, P A; Shetty, A C; Hakansson, A; Van der Eecken, K; Song, Y; Liu, Y; Chang, J; Fonteyne, V; Mendes, A A; Lumen, N; Delrue, L; Verbeke, S; De Man, K; Rana, Z; Hodges, T; Hamid, A; Roberts, N; Song, D Y; Pienta, K; Ross, A E; Feng, F; Joniau, S; Spratt, D; Gillessen, S; Attard, G; James, N D; Lotan, T; Davicioni, E; Sweeney, C; Tran, P T; Deek, M P; Ost, P.
Afiliação
  • Sutera PA; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Shetty AC; Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, USA; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, USA.
  • Hakansson A; Veracyte, San Diego, USA.
  • Van der Eecken K; Department of Pathology, Ghent University Hospital, Ghent, Belgium.
  • Song Y; Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, USA; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, USA.
  • Liu Y; Veracyte, San Diego, USA.
  • Chang J; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, USA.
  • Fonteyne V; Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium.
  • Mendes AA; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Lumen N; Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium.
  • Delrue L; Department of Radiology, Ghent University Hospital, Ghent, Belgium.
  • Verbeke S; Department of Pathology, Ghent University Hospital, Ghent, Belgium.
  • De Man K; Department of Nuclear Medicine, Ghent University Hospital, Ghent, Belgium.
  • Rana Z; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, USA.
  • Hodges T; Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, USA; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, USA.
  • Hamid A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Roberts N; Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Medical Institutions, Baltimore, USA.
  • Song DY; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, USA; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA; James Buchanan Brady Urological Institute, J
  • Pienta K; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA; James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, USA.
  • Ross AE; Department of Urology, Northwestern University, Chicago, USA.
  • Feng F; Department of Medicine, UCSF, San Francisco, USA; Department of Urology, UCSF, San Francisco, USA; Department of Radiation Oncology, UCSF, San Francisco, USA.
  • Joniau S; Department of Urology, Catholic University Leuven, Leuven, Belgium.
  • Spratt D; Department of Radiation Oncology, University Hospitals, Cleveland, USA.
  • Gillessen S; Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland.
  • Attard G; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • James ND; The Royal Marsden Hospital NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.
  • Lotan T; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Davicioni E; Veracyte, San Diego, USA.
  • Sweeney C; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia.
  • Tran PT; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, USA; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, USA.
  • Deek MP; Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, USA. Electronic address: matthewdeek@gmail.com.
  • Ost P; Department of Radiation Oncology, Iridium Network, Antwerp, Belgium; Department of Human Structure and Repair, Ghent University, Ghent, Belgium. Electronic address: piet.ost@ugent.be.
Ann Oncol ; 34(7): 605-614, 2023 07.
Article em En | MEDLINE | ID: mdl-37164128
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Produtos Biológicos / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans / Male Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Produtos Biológicos / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans / Male Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos